Permanens Capital L.P. Invests $1.55 Million in Humana Inc. $HUM

Permanens Capital L.P. purchased a new stake in Humana Inc. (NYSE:HUM) in the second quarter, according to its most recent filing with the SEC. The fund purchased 3,884 shares of the insurance provider’s stock, valued at approximately $1,546,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. BlackRock Inc. bought a new position in Humana during the second quarter worth $4,138,160,000. Pzena Investment Management LLC bought a new stake in Humana during the second quarter valued at $1,749,014,000. Capital International Investors raised its holdings in shares of Humana by 113.9% during the fourth quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider’s stock worth $1,490,239,000 after purchasing an additional 3,097,571 shares during the period. Norges Bank bought a new position in shares of Humana in the 4th quarter worth about $456,632,000. Finally, Wellington Management Group LLP boosted its holdings in shares of Humana by 4,481.7% in the 4th quarter. Wellington Management Group LLP now owns 1,196,502 shares of the insurance provider’s stock valued at $306,460,000 after buying an additional 1,170,387 shares during the period. 92.38% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

HUM has been the subject of several recent research reports. Wolfe Research reaffirmed an “outperform” rating and set a $450.00 target price on shares of Humana in a report on Monday. Jefferies Financial Group raised Humana from a “buy” rating to a “buy” rating in a report on Wednesday, May 20th. Weiss Ratings upgraded Humana from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, August 14th. UBS Group assumed coverage on Humana in a research note on Thursday, July 30th. They set a “buy” rating for the company. Finally, Truist Financial raised their target price on Humana from $320.00 to $415.00 and gave the company a “hold” rating in a research note on Tuesday, July 14th. Fourteen research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Humana currently has a consensus rating of “Hold” and a consensus target price of $403.91.

Humana Stock Performance

HUM opened at $390.06 on Thursday. The business’s 50 day moving average is $384.44 and its 200-day moving average is $286.38. The stock has a market cap of $46.84 billion, a PE ratio of 36.90, a price-to-earnings-growth ratio of 2.22 and a beta of 0.72. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.62. Humana Inc. has a twelve month low of $163.11 and a twelve month high of $428.88.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.27 by $0.34. Humana had a return on equity of 11.20% and a net margin of 0.88%.The business had revenue of $40.89 billion during the quarter, compared to analyst estimates of $40.58 billion. During the same period in the prior year, the company posted $6.27 EPS. The business’s revenue for the quarter was up 26.2% compared to the same quarter last year. On average, analysts predict that Humana Inc. will post 9.12 earnings per share for the current year.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.